Generic drug makerLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in IndiaLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 2 spellings of its name, each linked to the record.
As of Nov 14, 2026, FDA's public records list Strides Pharma Science and its 5 subsidiaries with 232 drug applications, 16 drug recalls and 2 warning letters. The most recent is a warning letter dated May 23, 2023: Warning letter: Drugs.
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date, Strides Pharma Science and its 5 subsidiaries
A hatched bar is a year that is not over, so its count covers only part of the year.
| May 23, 2023 | Warning letter: DrugsCDER | Warning letters |
| Aug 24, 2020 | Strides Pharma Inc.Potassium Chloride Extended-Release Tablets, USP 8mEq (600 mg) 100 Tablets Rx Only Manufactured by: Strides Pharma ScieClass II · Failed Dissolution Specifications | Drug recalls |
| Jul 1, 2019 | Warning letter: Data integrity, Out-of-specification, Quality unitCDER | Warning letters |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
